Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren SyndromeJAMA Network OpenNovember 10, 202210.1001/jamanetworkopen.2022.41451Cited by 88SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis